英文名稱
(S)-Hydroxy Des(boric Acid) Bortezomib
N-[(1S)-2-[[(1S)-1-羥基-3-甲基丁基]氨基]-2-氧代-1-(苯基甲基)乙基]-2-吡嗪甲酰胺
純度
No Data Available
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
Chloroform (Slightly), Methanol (Slightly)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.